Cytochrome P450 2E polymorphism in feline liver

Biochimica et Biophysica Acta - General Subjects

Volumn 1726, Issue 2, 2005, Pages 194-205

  Tanaka, Nagako ^a   Shinkyo, Raku ^b   Sakaki, Toshiyuki ^c   Kasamastu, Masahiko ^a   Imaoka, Susumu ^d   Funae, Yoshihiko ^e   Yokota, Hiroshi ^a  

^a RAKUNO GAKUEN UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c TOYAMA PREFECTURAL UNIVERSITY   (Japan)

^d KWANSEI GAKUIN UNIVERSITY   (Japan)

^e OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cat; CYP2E1; CYP2E2; Cytochrome P450 (CYP); Polymorphism

Indexed keywords

CHLORZOXAZONE; COMPLEMENTARY DNA; CYTOCHROME P450; CYTOCHROME P450 2E; ENZYME; GENOMIC DNA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL TISSUE; ARTICLE; CAT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME POLYMORPHISM; EXON; FEMALE; GENE EXPRESSION; INTESTINE; INTRON; KIDNEY; LIVER; LUNG; MALE; MONONUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH; YEAST CELL;

AMINO ACID SEQUENCE; ANIMALS; CATS; CHLORZOXAZONE; CLONING, MOLECULAR; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; EXONS; ISOENZYMES; KIDNEY; LEUKOCYTES, MONONUCLEAR; LIVER; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; PHYLOGENY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SUBSTRATE SPECIFICITY;

ANIMALIA; FELIDAE;

EID: 27644549611     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2005.08.004     Document Type: Article

References (48)

1. D.R. Nelson, L. Koymans, T. Kamataki, J.J. Stegeman, R. Feyereisen, D.J. Waxman, M.R. Waterman, O. Gotoh, M.J. Coon, R.W. Estabrook, I.C. Gunsalus, and D.W. Nebert P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature Pharmacogenetics 6 1996 1 42
2. D.R. Koop, and J.P. Casazza Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes J. Biol. Chem. 260 1985 13607 13612
3. Y. Imai Characterization of rabbit liver cytochrome P-450 (laurate omega-1 hydroxylase) synthesized in transformed yeast cells J. Biochem. (Tokyo) 103 1988 143 148
4. R.M. Laethem, M. Balazy, J.R. Falck, C.L. Laethem, and D.R. Koop Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1 J. Biol. Chem. 268 1993 12912 12918
5. T. Nakajima, E. Elovaara, T. Okino, H.V. Gelboin, M. Klockars, V. Riihimaki, T. Aoyama, and H. Vainio Different contributions of cytochrome P450 2E1 and P450 2B1/2 to chloroform hepatotoxicity in rat Toxicol. Appl. Pharmacol. 133 1995 215 222
6. E.T. Morgan, D.R. Koop, and M.J. Coon Comparison of six rabbit liver cytochrome P-450 isozymes in formation of a reactive metabolite of acetaminophen Biochem. Biophys. Res. Commun. 112 1983 8 13
7. M.J. Coon, D.R. Koop, and E.T. Morgan Alcohol oxidation by isozyme 3a of liver microsomal cytochrome P-450 Pharmacol. Biochem. Behav. 18 1983 177 180
8. R. Peter, R. Bocker, P.H. Beaune, M. Iwasaki, F.P. Guengerich, and C.S. Yang Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1 Chem. Res. Toxicol. 3 1990 566 573
9. L.D. Gruenke, K. Konopka, D.R. Koop, and L.A. Waskell Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay J. Pharmacol. Exp. Ther. 246 1988 454 459
10. J.L. Raucy, J.C. Kraner, and J.M. Lasker Bioactivation of halogenated hydrocarbons by cytochrome P4502E1 Crit. Rev. Toxicol. 23 1993 1 20
11. E.D. Kharasch, and K.E. Thummel Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane Anesthesiology 79 1993 795 807
12. E.D. Kharasch, D.C. Hankins, and K. Cox Clinical isoflurane metabolism by cytochrome P450 2E1 Anesthesiology 90 1999 766 771
13. E.D. Kharasch, A.S. Armstrong, K. Gunn, A. Artru, K. Cox, and M.D. Karol Clinical sevoflurane metabolism and disposition: II. The role of cytochrome P450 2E1 in fluoride and hexafluoroisopropanol formation Anesthesiology 82 1995 1379 1388
14. D.R. Koop, C.L. Laethem, and G.G. Schnier Identification of ethanol-inducible P450 isozyme 3a (P450IIE1) as a benzene and phenol hydroxylase Toxicol. Appl. Pharmacol. 98 1989 278 288
15. H. Yamazaki, Y. Oda, Y. Funae, S. Imaoka, Y. Inui, F.P. Guengerich, and T. Shimada Participation of rat liver cytochrome P450 2E1 in the activation of N-nitrosodimethylamine and N-nitrosodiethylamine to products genotoxic in an acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009) Carcinogenesis 13 1992 979 985
16. J.J. Hu, M.J. Lee, M. Vapiwala, K. Reuhl, P.E. Thomas, and C.S. Yang Sex-related differences in mouse renal metabolism and toxicity of acetaminophen Toxicol. Appl. Pharmacol. 122 1993 16 26
17. C.J. Patten, P.E. Thomas, R.L. Guy, M. Lee, F.J. Gonzalez, F.P. Guengerich, and C.S. Yang Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics Chem. Res. Toxicol. 6 1993 511 518
18. E. Eliasson, and J.G. Kenna Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis Mol. Pharmacol. 50 1996 573 582
19. D. Njoku, M.J. Laster, D.H. Gong, E.I. Eger II, G.F. Reed, and J.L. Martin Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury Anesth. Analg. 84 1997 173 178
20. C.S. Lieber Susceptibility to alcohol-related liver injury Alcohol Alcohol., Suppl. 2 1994 315 326
21. S.C. Khani, T.D. Porter, V.S. Fujita, and M.J. Coon Organization and differential expression of two highly similar genes in the rabbit alcohol-inducible cytochrome P-450 subfamily J. Biol. Chem. 263 1988 7170 7175
22. I.D. Capel, M.R. French, P. Millburn, R.L. Smith, and R.T. Williams The fate of (14C)phenol in various species Xenobiotica 2 1972 25 34
23. I.D. Capel, P. Millburn, and R.T. Williams The conjugation of 1- and 2-naphthols and other phenols in the cat and pig Xenobiotica 4 1974 601 615
24. J.B. Watkins III, and C.D. Klaassen Xenobiotic biotransformation in livestock: comparison to other species commonly used in toxicity testing J. Anim. Sci. 63 1986 933 942
25. M.H. Court, and D.J. Greenblatt Molecular basis for deficient acetaminophen glucuronidation in cats. An interspecies comparison of enzyme kinetics in liver microsomes Biochem. Pharmacol. 53 1997 1041 1047
26. M.H. Court, and D.J. Greenblatt Biochemical basis for deficient paracetamol glucuronidation in cats: an interspecies comparison of enzyme constraint in liver microsomes J. Pharm. Pharmacol. 49 1997 446 449
27. M.H. Court, and D.J. Greenblatt Molecular genetic basis for deficient acetaminophen glucuronidation by cats: UGT1A6 is a pseudogene, and evidence for reduced diversity of expressed hepatic UGT1A isoforms Pharmacogenetics 10 2000 355 369
28. D.C. Eberhart, B. Gemzik, M.R. Halvorson, and A. Parkinson Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin Mol. Pharmacol. 40 1991 859 867
29. R. Pearce, D. Greenway, and A. Parkinson Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation Arch. Biochem. Biophys. 298 1992 211 225
30. N. Chauret, A. Gauthier, J. Martin, and D.A. Nicoll-Griffith In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse Drug Metab. Dispos. 25 1997 1130 1136
31. M.H. Court, L.L. Von Moltke, R.I. Shader, and D.J. Greenblatt Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species Biopharm. Drug Dispos. 18 1997 213 226
32. M.A. Frohman, M.K. Dush, and G.R. Martin Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer Proc. Natl. Acad. Sci. U. S. A. 85 1988 8998 9002
33. S. Kunitoh, S. Imaoka, T. Hiroi, Y. Yabusaki, T. Monna, and Y. Funae Acetaldehyde as well as ethanol is metabolized by human CYP2E1 J. Pharmacol. Exp. Ther. 280 1997 527 532
34. R. Shinkyo, T. Sakaki, T. Takita, M. Ohta, and K. Inouye Generation of 2,3,7,8-TCDD-metabolizing enzyme by modifying rat CYP1A1 through site-directed mutagenesis Biochem. Biophys. Res. Commun. 308 2003 511 517
35. H. Yokota, N. Ohgiya, G. Ishihara, K. Ohta, and A. Yuasa Purification and properties of UDP-glucuronyltransferase from kidney microsomes of beta-naphthoflavone-treated rat J. Biochem. (Tokyo) 106 1989 248 252
36. T. Omura, and R. Sato The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature J. Biol. Chem. 239 1964 2370 2378
37. S. Imaoka, Y. Terano, and Y. Funae Changes in the amount of cytochrome P450s in rat hepatic microsomes with starvation Arch. Biochem. Biophys. 278 1990 168 178
38. J.G. Howe, and J.W. Hershey A sensitive immunoblotting method for measuring protein synthesis initiation factor levels in lysates of Escherichia coli J. Biol. Chem. 256 1981 12836 12839
39. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
40. T. Omura, and S. Takesue A new method for simultaneous purification of cytochrome b5 and NADPH-cytochrome c reductase from rat liver microsomes J. Biochem. (Tokyo) 67 1970 249 257
41. O. Gotoh Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences J. Biol. Chem. 267 1992 83 90
42. T.L. Poulos, B.C. Finzel, and A.J. Howard High-resolution crystal structure of cytochrome P450cam J. Mol. Biol. 195 1987 687 700
43. Y. Imai, and M. Nakamura The importance of threonine-301 from cytochromes P-450 (laurate (omega-1)-hydroxylase and testosterone 16 alpha-hydroxylase) in substrate binding as demonstrated by site-directed mutagenesis FEBS Lett. 234 1988 313 315
44. H. Yamazaki, M. Nakano, E.M. Gillam, L.C. Bell, F.P. Guengerich, and T. Shimada Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes Biochem. Pharmacol. 52 1996 301 309
45. T.D. Porter, S.C. Khani, and M.J. Coon Induction and tissue-specific expression of rabbit cytochrome P450IIE1 and IIE2 genes Mol. Pharmacol. 36 1989 61 65
46. H.M. Peng, T.D. Porter, X.X. Ding, and M.J. Coon Differences in the developmental expression of rabbit cytochromes P-450 2E1 and 2E2 Mol. Pharmacol. 40 1991 58 62
47. H.M. Peng, and M.J. Coon Promoter function and the role of cytokines in the transcriptional regulation of rabbit CYP2E1 and CYP2E2 Arch. Biochem. Biophys. 382 2000 129 137
48. D.R. Nelson, D.C. Zeldin, S.M. Hoffman, L.J. Maltais, H.M. Wain, and D.W. Nebert Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants Pharmacogenetics 14 2004 1 18